ネム

[しりひとみ @sirisiri_hit]

https://t.co/EN8DbHZp8T

[ネム @TY16058114]

@inakkusu_TOTR はらはらふさ。さ、し、さ、さ、さ、

[Contextpinit bluesky @blueskypinit]

He felt safe… until THIS happened 👀

[ImmunityBio, Inc. @ImmunityBio]

Access to innovative cancer therapies continues to expand. ANKTIVA® is now available in Saudi Arabia for patients with bladder and lung cancers, marking an important step in ImmunityBio’s global efforts to reach more patients.

Read more: https://t.co/DwjGwcpkp5

[Dr. Pat Soon-Shiong @DrPatrick]

Here we go with the drumbeat of evidence of how lymphopenia results in poorer prognosis in breast cancer, regardless of type and regardless of stage by Dr. Aditya Bardia, a renowned UCLA breast cancer oncologist.

#1 Dec 2025:
Early stage TRIPLE NEGATIVE BREAST CANCER at San Antonio Breast Cancer Symposium (SABCS): A study demonstrating that lymphopenia is associated with statistically LOWER pathological complete response (pCR) rates in patients with early-stage triple negative breast cancer (TNBC) treated with neoadjuvant chemo-immunotherapy.

News tomorrow at @AACR on Stage 1, 2, and 3 breast cancer.

https://t.co/NXlDRAxzez

[Humanspective @Humanspective]

🚨Dr. Patrick Soon-Shiong - “I have focused my efforts on the Natural Killer cell... but once you have an infection or covid or chemotherapy, radiation, you wipe out these natural killer cells, which makes completely no logic”

“This confirms our greatest fears... the S protein even from the [injection] is immunosuppressive resulting in lower T cells”

[ImmunityBio, Inc. @ImmunityBio]

As we look ahead to the 2026 @BladderCancerUS walks, we're proud to stand alongside the bladder cancer community.

Immunitybio is honored to sponsor these events and be part of the collective effort to raise awareness and support patients and caregivers in their cancer journeys. Register for a walk near you: https://t.co/5EDLHXsYvD

[Dr. Pat Soon-Shiong @DrPatrick]

Treating patients dying of sepsis only with antibiotics and cardiac supportive care while ignoring the collapse of the immune system is like a horse with blinders and with limited peripheral vision. The year of the fire horse is here.

Scientific research on the dynamic state of immune dysfunction and lymphopenia in patients dying of sepsis coming soon. Stay tuned.

Sepsis is the most expensive condition managed in U.S. hospitals. Hospital costs for sepsis soared from $31.2 billion in 2016 to $52.1 billion in 2021.

In 2021, one in six patients with sepsis died in the hospital; among sepsis hospital encounters
involving septic shock, one in three stays resulted in death.

https://t.co/5SLUOUbdka

[Dr. Pat Soon-Shiong @DrPatrick]

Capital in place.Approvals in 34 countries. Indication expansion globally in motion. Pipeline of combination trials cooking. Immunotherapy 2.0. Never give up.

[ImmunityBio, Inc. @ImmunityBio]

At ImmunityBio, we continue to prioritize long-term growth and the advancement of our broader immunotherapy platform.

This additional non-dilutive financing supports our effort to expand globally with the goal of improving outcomes for patients. Read more: https://t.co/VeXdDn59Ka

[怪盗カラス @Phantom_crow_]

ゲーミングPC5年分を"勝手に"プレゼントします🐦‍⬛

[Dr. Pat Soon-Shiong @DrPatrick]

Great announcement today by HHS and NCI to support cancer vaccine trials. We have spent the past decade collaborating with 2 amazing thought leaders at the National Cancer Institute (NCI) in the field of cancer vaccine, Dr James Gulley and Dr Jeffrey Schlom.

Together we have completed Phase 1 & 2 trials across multiple tumor types showing how our Adeno vaccine plus Anktiva generates tumor specific T cells. The randomized trial to PREVENT cancer in subjects with Lynch Syndrome which affects over a million Americans (1 in 278) is fully enrolled and the early data so far shows that Anktiva and the Adeno vaccine increases NK and T cells in these subjects, even in subjects aged 65

https://t.co/3why0GKjVk

[KarasuGaming【公式】 @KarasuGamingBTO]

ゲーミングPC5年分プレゼントします💡🐦‍⬛

[Dr. Pat Soon-Shiong @DrPatrick]

Incredible, @MK2forU connected the dots that I have been trying for decades to do. I'm glad this comes from a scientist unrelated to @ImmunityBio and speaking about the future of cancer care. The future is here. Certain countries have recognized the opportunity and are eagerly embracing this future. Fighting hard for American patients. Please read this substack analysis. It is deeper than any analyst I have read and connects the dots beautifully of information we have published over time.

https://t.co/we1v1Gijgy

[Dr. Pat Soon-Shiong @DrPatrick]

The world bank of natural killer cells is close. Data from production of billions of NK cells and successful cryopreservation from pver 60 healthy volunteers and cancer patients coming soon. The Leonardo AI driven robot will transform the availability of NK cells globally.

[さいぴ🐣 (saip) @_saip_]

GPT5.4による人類最後の日のなんJスレ

[ローソン @akiko_lawson]

5日間限定の無料券チャレンジ(^^)
今日はのむヨーグルト無料の4日目です♪

1）このアカウントをフォロー
2）この投稿をリポスト
3）抽選で毎日1万名様に無料券！結果は自動でお知らせ

[神谷宗幣【参政党】 @jinkamiya]

【党員の皆さんへお願い】

参政党の成長に伴い、
今まで以上に誹謗中傷を受けたり、
SNS上で心ない言葉を
投げかけられることも増えました。

悔しくて、言い返したくなりますね。

しかし、そういった時でも
「やり返す」
「汚い言葉で応じる」ことは
やめておきましょう。

政策の問題点を指摘したり、
誤りを訂正することは大切です。

ただし、個人に対する
人格攻撃などはいけません。
それは政治の本筋から外れた
「場外乱闘」です。

また不確かな情報を憶測で流すことは信頼を失う元です。
そこも気をつけていきましょう。

不当な妨害や犯罪的な行為もひどくなっていますが、それらはしっかりと公に訴えて抗議していきます。

以前も書きましたが
私たち参政党は正々堂々と
選挙や議会で戦う政党で
ありたいと思っています。

参政党に関わる皆さん
一人ひとりの振る舞いが、
その姿勢を世に示す力になりますから
ネット上でも丁寧に
そして誠実にやっていきましょう。

古くからの党員さんは
慣れている方も多い
とは思いますが、
最近参政党に入った方も
いらっしゃると思うので改めて
この姿勢をご理解下さい。

活動の中で世の中に感じる不条理は
全て自己成長のエネルギーに
変えてやろうと腹に決めて
日々取り組んでいます。

何のための参政党かを忘れずに
一緒に頑張りましょう。

[p @p_ka2295079]

世にも奇妙な物語かと思った

[MUMA @MUMA_maximum76]

征伐しに出かけるんやって